全文获取类型
收费全文 | 559篇 |
免费 | 49篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 13篇 |
妇产科学 | 12篇 |
基础医学 | 49篇 |
口腔科学 | 41篇 |
临床医学 | 28篇 |
内科学 | 137篇 |
皮肤病学 | 16篇 |
神经病学 | 24篇 |
特种医学 | 15篇 |
外科学 | 125篇 |
综合类 | 16篇 |
预防医学 | 24篇 |
眼科学 | 9篇 |
药学 | 32篇 |
中国医学 | 10篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 14篇 |
2022年 | 32篇 |
2021年 | 36篇 |
2020年 | 17篇 |
2019年 | 35篇 |
2018年 | 31篇 |
2017年 | 25篇 |
2016年 | 20篇 |
2015年 | 18篇 |
2014年 | 32篇 |
2013年 | 29篇 |
2012年 | 39篇 |
2011年 | 47篇 |
2010年 | 24篇 |
2009年 | 14篇 |
2008年 | 14篇 |
2007年 | 14篇 |
2006年 | 11篇 |
2005年 | 19篇 |
2004年 | 5篇 |
2003年 | 8篇 |
2002年 | 10篇 |
2001年 | 5篇 |
2000年 | 9篇 |
1999年 | 6篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 2篇 |
1993年 | 3篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 9篇 |
1987年 | 6篇 |
1985年 | 4篇 |
1984年 | 7篇 |
1976年 | 2篇 |
1970年 | 1篇 |
1941年 | 2篇 |
1940年 | 1篇 |
1939年 | 1篇 |
1938年 | 2篇 |
1937年 | 4篇 |
1936年 | 1篇 |
1932年 | 1篇 |
1929年 | 4篇 |
1927年 | 2篇 |
排序方式: 共有610条查询结果,搜索用时 15 毫秒
21.
22.
Zain Irfan Khatib Suhas S Haldipurkar Vijay Shetty Harsha Dahake Pranoti Nagvekar Priyanka Kashelkar 《Indian journal of ophthalmology》2021,69(3):580
Purpose:The aim of this study is to evaluate the accuracy of three newer generation formulae (Barrett Universal II, EVO, Hill-RBF 2.0) for calculation of power of two standard IOLs—the Acrysof IQ and Tecnis ZCB00 across all axial lengths.Methods:In this retrospective series, 206 eyes of 206 patients, operated for cataract surgery with above two IOLs over the last 6 months, were included in the study. Preoperative biometry measurements were obtained from LenstarLS900. By using recommended lens constants, the mean error for each formula was calculated and compared. Then, the optimized IOL constants were calculated to reduce the mean error to zero. Mean and median absolute errors were calculated for all eyes and separately for short (AL<22.5 mm), medium (22.5–24.5 mm), and long eyes (>24.5 mm). Absolute errors and percentages of eyes within prediction errors of ±0.25 D, ±0.50 D, ±0.75 D, and ±1.00 D were compared.Results:Prediction error with using recommended lens constants was significantly lower in the Barrett Universal II formula as compared to the other two formulae. However, after optimizing lens constants, there were no significant differences in the absolute errors between the three formulae. The formulae ranked by mean absolute error were as follows: Barrett Universal II (0.304 D), EVO (0.317 D), and Hill-RBF (0.322) D. There were no significant differences between absolute errors in the three formulae in each of the short-, medium-, and long-eye subgroups.Conclusion:With proper lens constant optimization, the Barrett Universal II, EVO, and Hill-RBF 2.0 formulae were equally accurate in predicting IOL power across the entire range of axial lengths. 相似文献
23.
24.
25.
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma 总被引:11,自引:0,他引:11 下载免费PDF全文
Nademanee A Forman S Molina A Fung H Smith D Dagis A Kwok C Yamauchi D Anderson AL Falk P Krishnan A Kirschbaum M Kogut N Nakamura R O'donnell M Parker P Popplewell L Pullarkat V Rodriguez R Sahebi F Smith E Snyder D Stein A Spielberger R Zain J White C Raubitschek A 《Blood》2005,106(8):2896-2902
We conducted a phase 1/2 trial of high-dose 90Y-ibritumomab tiuxetan in combination with high-dose etoposide (VP-16) 40 to 60 mg/kg (day -4) and cyclophosphamide 100 mg/kg (day -2) followed by autologous stem cell transplantation (ASCT) in 31 patients with CD20+ non-Hodgkin lymphoma (NHL). Patients underwent dosimetry (day -21) with 5 mCi (185 MBq) 111In-ibritumomab tiuxetan following 250 mg/m2 rituximab, followed a week later by 90Y-ibritumomab tiuxetan to deliver a target dose of 1000 cGy to highest normal organ. Bone marrow biopsy was done on day -7 to estimate radiation dose and stem cells were reinfused when the radiation dose was estimated to be less than 5 cGy. The median 90Y-ibritumomab tiuxetan dose was 71.6 mCi (2649.2 MBq; range, 36.6-105 mCi; range, 1354.2-3885 MBq). Histology included follicular lymphoma (n = 12), diffuse large B-cell (n = 14), and mantle cell (n = 5). The median number of prior chemo-therapy treatments was 2. The treatment was well tolerated. The median times to reach an absolute neutrophil count greater than 500/microL and platelet count more than 20,000/microL were 10 days and 12 days, respectively. There were 2 deaths and 5 relapses. At a median follow-up of 22 months, the 2-year estimated overall survival and relapse-free survival rates are 92% and 78%, respectively. We conclude that high-dose 90Y-ibritumomab tiuxetan can be combined safely with high-dose etoposide and cyclophosphamide without an increase in transplant-related toxicity or delayed engraftment. 相似文献
26.
Efficient coupled transcription and mRNA splicing in vitro using plasmids derived from early region 3 of adenovirus 2 and a nondefective adenovirus-simian virus 40 hybrid. 总被引:1,自引:0,他引:1 下载免费PDF全文
S Pawar C M Ahmed R Watkins S Zain 《Proceedings of the National Academy of Sciences of the United States of America》1984,81(9):2679-2683
Accurate and highly efficient (80%) splicing of a single mRNA precursor to processed products was achieved using HeLa cell extracts to synthesize and process RNA in vitro from recombinant plasmids containing specific DNA segments from adenovirus 2 (Ad2) and the nondefective adenovirus-simian virus 40 (Ad+2ND1) hybrid. One plasmid, pRID, contains a segment of Ad2 DNA spanning chromosome map coordinates 75.9-83.4. The other plasmid, pRW9, contains the analogous viral region from Ad+2ND1. RNA synthesis from pRID in vitro occurs for more than 60 min and is directed by RNA polymerase II. RNA products consistent in size with the expected precursor and the two processed mRNAs are made. RNA blot hybridization analyses showed that these products are complementary to the Ad2 insert in the plasmid and that the appropriate intervening sequence was absent from the smallest processed mRNA. Comparison of the splice patterns of RNA made in vitro to those of RNAs taken from infected cells using the nuclease S1 technique demonstrated the accuracy of intron removal. 相似文献
27.
28.
29.
Kevin Y. Zhan MD Sidharth V. Puram MD PhD Michael M. Li MD Dustin A. Silverman MD Amit A. Agrawal MD Enver Ozer MD Matthew O. Old MD Ricardo L. Carrau MD James W. Rocco MD PhD Kevin M. Higgins MD MSc Danny J. Enepekides MD MPH Zain Husain MD Stephen Y. Kang MD Antoine Eskander MD ScM 《Cancer》2020,126(6):1295-1305
30.
Translation of First North American 50 and 70 cc Total Artificial Heart Virtual and Clinical Implantations: Utility of 3D Computed Tomography to Test Fit Devices 下载免费PDF全文
Alice S. Ferng Isabel Oliva Clinton Jokerst Ryan Avery Alana M. Connell Phat L. Tran Richard G. Smith Zain Khalpey 《Artificial organs》2017,41(8):727-734
Since the creation of SynCardia's 50 cc Total Artificial Hearts (TAHs), patients with irreversible biventricular failure now have two sizing options. Herein, a case series of three patients who have undergone successful 50 and 70 cc TAH implantation with complete closure of the chest cavity utilizing preoperative “virtual implantation” of different sized devices for surgical planning are presented. Computed tomography (CT) images were used for preoperative planning prior to TAH implantation. Three‐dimensional (3D) reconstructions of preoperative chest CT images were generated and both 50 and 70 cc TAHs were virtually implanted into patients' thoracic cavities. During the simulation, the TAHs were projected over the native hearts in a similar position to the actual implantation, and the relationship between the devices and the atria, ventricles, chest wall, and diaphragm were assessed. The 3D reconstructed images and virtual modeling were used to simulate and determine for each patient if the 50 or 70 cc TAH would have a higher likelihood of successful implantation without complications. Subsequently, all three patients received clinical implants of the properly sized TAH based on virtual modeling, and their chest cavities were fully closed. This virtual implantation increases our confidence that the selected TAH will better fit within the thoracic cavity allowing for improved surgical outcome. Clinical implantation of the TAHs showed that our virtual modeling was an effective method for determining the correct fit and sizing of 50 and 70 cc TAHs. 相似文献